Fabienne Langlois

1.1k total citations · 1 hit paper
21 papers, 605 citations indexed

About

Fabienne Langlois is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Fabienne Langlois has authored 21 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 2 papers in Genetics. Recurrent topics in Fabienne Langlois's work include Pituitary Gland Disorders and Treatments (16 papers), Adrenal and Paraganglionic Tumors (11 papers) and Growth Hormone and Insulin-like Growth Factors (9 papers). Fabienne Langlois is often cited by papers focused on Pituitary Gland Disorders and Treatments (16 papers), Adrenal and Paraganglionic Tumors (11 papers) and Growth Hormone and Insulin-like Growth Factors (9 papers). Fabienne Langlois collaborates with scholars based in Canada, United States and Singapore. Fabienne Langlois's co-authors include Maria Fleseriu, Dawn Shao Ting Lim, Elena V Varlamov, Shirley McCartney, Шломо Мелмед, Justin S. Cetas, Jeffrey Wagner, Chris G. Yedinak, Ahmet Baki Dogan and Greisa Vila and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Nature Reviews Endocrinology.

In The Last Decade

Fabienne Langlois

20 papers receiving 602 citations

Hit Papers

Acromegaly: pathogenesis, diagnosis, and management 2022 2026 2023 2024 2022 25 50 75 100

Peers

Fabienne Langlois
Fabienne Langlois
Citations per year, relative to Fabienne Langlois Fabienne Langlois (= 1×) peers Orsalia Alexopoulou

Countries citing papers authored by Fabienne Langlois

Since Specialization
Citations

This map shows the geographic impact of Fabienne Langlois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabienne Langlois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabienne Langlois more than expected).

Fields of papers citing papers by Fabienne Langlois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabienne Langlois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabienne Langlois. The network helps show where Fabienne Langlois may publish in the future.

Co-authorship network of co-authors of Fabienne Langlois

This figure shows the co-authorship network connecting the top 25 collaborators of Fabienne Langlois. A scholar is included among the top collaborators of Fabienne Langlois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabienne Langlois. Fabienne Langlois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleseriu, Maria, Elena V Varlamov, Amit Akirov, et al.. (2025). Prolactin-secreting adenomas: pathogenesis, diagnosis, and management. The Lancet Diabetes & Endocrinology. 13(10). 874–890. 3 indexed citations
2.
Fleseriu, Maria, Mirjam Christ‐Crain, Fabienne Langlois, Mônica R. Gadelha, & Шломо Мелмед. (2024). Hypopituitarism. The Lancet. 403(10444). 2632–2648. 25 indexed citations
3.
Fleseriu, Maria, Elena V Varlamov, José Miguel Hinojosa‐Amaya, Fabienne Langlois, & Шломо Мелмед. (2023). An individualized approach to the management of Cushing disease. Nature Reviews Endocrinology. 19(10). 581–599. 35 indexed citations
4.
Yuen, Kevin C.J., et al.. (2023). Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop. Endocrine Practice. 30(3). 282–291.
5.
Fleseriu, Maria, Fabienne Langlois, Dawn Shao Ting Lim, Elena V Varlamov, & Шломо Мелмед. (2022). Acromegaly: pathogenesis, diagnosis, and management. The Lancet Diabetes & Endocrinology. 10(11). 804–826. 110 indexed citations breakdown →
6.
Langlois, Fabienne & Maria Fleseriu. (2021). What to Do with Incidentally Discovered Pituitary Abnormalities?. Medical Clinics of North America. 105(6). 1081–1098. 6 indexed citations
7.
Lim, Dawn Shao Ting, et al.. (2021). Hypercoagulability in Cushing’s syndrome: From arterial to venous disease. Best Practice & Research Clinical Endocrinology & Metabolism. 35(2). 101496–101496. 12 indexed citations
8.
Varlamov, Elena V, Fabienne Langlois, Greisa Vila, & Maria Fleseriu. (2021). MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing’s syndrome: a practical approach. European Journal of Endocrinology. 184(5). R207–R224. 35 indexed citations
9.
Langlois, Fabienne, Elena V Varlamov, & Maria Fleseriu. (2021). Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease. The Journal of Clinical Endocrinology & Metabolism. 107(1). 10–28. 63 indexed citations
10.
Wagner, Jeffrey, Fabienne Langlois, Dawn Shao Ting Lim, Shirley McCartney, & Maria Fleseriu. (2019). Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis. Frontiers in Endocrinology. 9. 805–805. 71 indexed citations
11.
Langlois, Fabienne, Dawn Shao Ting Lim, Shirley McCartney, et al.. (2018). High prevalence of adrenal insufficiency at diagnosis and headache recovery in surgically resected Rathke’s cleft cysts—a large retrospective single center study. Endocrine. 63(3). 463–469. 19 indexed citations
12.
Langlois, Fabienne, et al.. (2018). Pituitary-Directed Therapies for Cushing’s Disease. Frontiers in Endocrinology. 9. 164–164. 21 indexed citations
13.
Langlois, Fabienne, Randall L. Woltjer, Justin S. Cetas, & Maria Fleseriu. (2018). Silent somatotroph pituitary adenomas: an update. Pituitary. 21(2). 194–202. 21 indexed citations
14.
Langlois, Fabienne, Dawn Shao Ting Lim, Elena V Varlamov, et al.. (2017). Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience. Endocrine. 58(3). 528–534. 29 indexed citations
15.
Langlois, Fabienne, Dawn Shao Ting Lim, Chris G. Yedinak, et al.. (2017). Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary. 21(1). 32–40. 56 indexed citations
16.
Langlois, Fabienne, et al.. (2017). Falsely Elevated Steroid Hormones in a Postmenopausal Woman Due to Laboratory Interference. Journal of the Endocrine Society. 1(8). 1062–1066. 13 indexed citations
17.
Langlois, Fabienne, Dawn Shao Ting Lim, & Maria Fleseriu. (2017). Update on adrenal insufficiency: diagnosis and management in pregnancy. Current Opinion in Endocrinology Diabetes and Obesity. 24(3). 184–192. 32 indexed citations
18.
Langlois, Fabienne, Marie‐France Langlois, André C. Carpentier, et al.. (2011). Ghrelin levels are associated with hunger as measured by the Three-Factor Eating Questionnaire in healthy young adults. Physiology & Behavior. 104(3). 373–377. 14 indexed citations
19.
Langlois, Fabienne, et al.. (2009). Current procedures for managing polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology. 5(1). 77–91. 5 indexed citations
20.
Bravo, Gina, et al.. (2004). Quebec Physicians' Knowledge and Opinions regarding Substitute Consent for Decisionally Incapacitated Older Adults. IRB Ethics and Human Research. 26(5). 12–12. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026